Contact this trialFirst, we need to learn more about you.
PD-1 Inhibitor
Nivolumab for Lung Cancer Prevention in Smokers
Recruiting1 awardPhase 2
Denver, Colorado
This trial will test whether the immunotherapy drug nivolumab can improve conditions in the airway of people at high risk for developing lung cancer. The safety of nivolumab will also be monitored.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.